UK markets closed

Iovance Biotherapeutics, Inc. (IOVA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.65+0.30 (+2.95%)
As of 11:47AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts12121010
Avg. Estimate-0.34-0.29-1.34-0.72
Low estimate-0.44-0.45-1.79-1.52
High estimate-0.29-0.14-1-0.01
Year ago EPS-0.47-0.46-1.89-1.34
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts12121211
Avg. Estimate29.29M54.99M161.19M442.21M
Low estimate5.2M11.2M33.2M130.5M
High estimate56.77M85M248.7M620.34M
Year ago sales238k469k1.19M161.19M
Sales growth (year/est)12,206.70%11,624.90%13,456.80%174.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.8-0.45-0.43-0.42
Actual EPS-0.47-0.46-0.45-0.42
Difference0.33-0.01-0.020
Surprise %41.30%-2.20%-4.70%0.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.34-0.29-1.34-0.72
7 days ago-0.35-0.28-1.27-0.73
30 days ago-0.36-0.29-1.29-0.71
60 days ago-0.36-0.29-1.29-0.71
90 days ago-0.37-0.31-1.37-0.96
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days7654
Up last 30 days8777
Down last 7 daysN/AN/AN/AN/A
Down last 30 days3443
Growth estimatesIOVAIndustrySector(s)S&P 500
Current qtr.27.70%N/AN/AN/A
Next qtr.37.00%N/AN/AN/A
Current year29.10%N/AN/AN/A
Next year46.30%N/AN/AN/A
Next 5 years (per annum)-19.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A